Jerrie S Refuerzo , MD

Ashley K. Amsbaugh, MD, is a double board-certified and fellowship-trained in anesthesiology and pain management specialist. She's experienced in all aspects of interventional pain medicine, including:Facet injections, medial branch nerve blocks, and radiofrequency ablationsSacroiliac joint injectionsTransforaminal, interlaminar, and caudal epidural injectionsGreater and lesser occipital nerve blocksBotox for chronic migrainesTrigger point injectionsLarge joint injectionsGenicular nerve blocksSpinal cord stimulator trialsStellate, celiac plexus, lumbar sympathetic, superior hypogastric and ganglion of impar blocks, and neurolysisAmsbaugh has co-authored numerous articles for peer-reviewed publications, including the Journal of Clinical Anesthesia, Brachytherapy, Pain Research and Treatment, and the Journal of Cardiothoracic and Vascular Anesthesia. Her clinical interests include all aspects of pain medicine, specifically neuraxial pain.She's a member of the American Society of Interventional Pain Physicians, Texas Pain Society, American Society of Regional Anesthesia, and American Society of Anesthesiologists.

Anthony Johnson, DO, is a board-certified and fellowship-trained maternal-fetal medicine specialist with expertise in fetal surgery for complicated monochorionic multifetal pregnancies, twin-to-twin transfusion syndrome, selective fetal growth restriction, and fetoscopic endotracheal occlusion for congenital diaphragmatic hernia. He is also a professor with the Department of Obstetrics, Gynecology and Reproductive Sciences at McGovern Medical School UTHealth Houston and the co-director of the UTHealth Houston Fetal Center. Johnson is renowned in fetal surgery and maternal-fetal medicine. He is involved in a renal anhydramnios fetal therapy study about treatment for mothers and their babies affected by early pregnancy renal anhydramnios. Before joining UTHealth Houston, Johnson was a professor at Baylor College of Medicine in Houston in the Department of Obstetrics and Gynecology, the Michael E. DeBakey Department of Surgery, and the Department of Molecular and Human Genetics. Johnson received his medical degree from West Virginia School of Osteopathic Medicine in Lewisburg. Subsequently, he completed his fellowship in Maternal-Fetal Medicine at Pennsylvania Hospital and a fellowship in medical genetics at Thomas Jefferson University Hospital, both in Philadelphia. He later served as the director of the Fetal Intervention Program in the Division of Maternal-Fetal Medicine at North Carolina Women’s Hospital in Chapel Hill, North Carolina, before moving to Houston in 2006. Johnson is an examiner on the Maternal Fetal Medicine Subspecialty Committee of the American Osteopathic Board of Obstetrics and Gynecology and the Medical Advisory Board of the Fetal Health Foundation. He has served as director of the Society for Maternal-Fetal Medicine’s Special Interest Group in Maternal-Fetal Surgery and Special Interest Group in Genetics. He was also a reviewer of the National Institutes of Child Health and Human Development, which sponsored the Management of Myelomeningocele Study published in the New England Journal of Medicine in 2011. Additionally, Johnson was the 2023 recipient of the Lifetime Achievement Award from the North American Fetal Therapy Network (NAFTNET).

Jimmy Espinoza, MD, MSc is a board-certified OB-GYN specialist with a diploma in fetal medicine. His clinical interests include in utero interventions for the management of twin-to-twin transfusion syndrome, lower fetal urinary tract obstructions, fetal pleural effusions, congenital diaphragmatic hernia, and fetal neural tube defects. Espinoza is a professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at McGovern Medical School at UTHealth Houston. Espinoza’s research focus is the use of biomarkers for stratification of risk to develop severe features in patients suspected to have preeclampsia. He is the lead author of the latest American College of Obstetricians and Gynecologists practice bulletin for diagnosing and managing gestational hypertension and preeclampsia. Espinoza received his medical degree from the National University of San Marcos in Peru. He then completed his residencies at San Fernando Faculty of Medicine, National University of San Marcos, Lima, Peru and at William Beaumont Hospital in Michigan. Espinoza completed fellowship training in fetal medicine at the Fetal Medicine Foundation in London, United Kingdom. He also served as a research fellow for the Perinatology Research Branch of the National Institute of Child Health and Human Development and then as an associate professor in the Department of Obstetrics and Gynecology of Wayne State University in Detroit, Michigan. Additionally, he holds a Master of Science (MSc) in reproductive health from the University of Wales in the United Kingdom. Espinoza has numerous awards for his contributions to obstetrics, gynecology, and maternal-fetal medicine. These include one of the top 2% of scientists most frequently cited worldwide by PLOS Biology, the Norton Rose Fulbright Faculty Excellence Award from Baylor College of Medicine for excellence in the development of enduring educational materials, and the lead author of one of the top 10 cited articles in the American Journal of Obstetrics & Gynecology. Espinoza is a member of the American College of Obstetricians and Gynecologists Committee on Clinical Practice Guidelines in Obstetrics. In addition to his clinical work, Espinoza is a member of the editorial boards of Ultrasound in Obstetrics and Gynecology, the Journal of Ultrasound in Medicine, and Fetal Diagnosis and Therapy. He has served on several national committees as a reviewer and grant reviewer. Espinoza has obtained several NIH grants with over $2 million in federal funding throughout his career.